Ann: Pause in Trading, page-49

They have already shown that they can arrive at two different conclusions though, not all the MACs even proposed an LCD in the first place so they definitely don't always agree on things. The private insurers are also definitely not in agreement either (ie CIGNA recently expanded coverage to include our procedure). CMS also slightly increased reimbursement for canaloplasty prior to the change in the LCD. The system over there seems to be quite a mess, every man for themself, I don't know why they would have separate MACs for different regions but they do. Also if they were all in agreement, wouldn't they have come out and made the decision together (which is usually the case)?

It is harder to regain lost customers, but we have the base effect in our favour as this is still a small company with a brand new product. If we lose 50% of customers, we only need to regain 100 customers whilst SGHT needs to regain 500. For us, we have a brand new device which should provide the impetus for at least 100 new customers to come on board (given there are regions in the US which are still covered plus there is also the RoW).